Literature DB >> 11156570

Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine.

C Maertens1, G Droogmans, P Chakraborty, B Nilius.   

Abstract

1. We have used the whole-cell patch clamp technique to study the effect of the partial anti-oestrogens clomiphene and nafoxidine, the pure anti-oestrogens ICI 182,780 and RU 58,668 and the oestrogen ss-estradiol, on the volume-regulated anion channel (VRAC) in cultured pulmonary artery endothelial (CPAE) cells. 2. In contrast to the pure anti-oestrogens and ss-estradiol, clomiphene and nafoxidine potently inhibited the volume-sensitive chloride current, I(Cl,swell), activated by challenging CPAE cells with a 25% hypotonic solution. For clomiphene, the estimated IC(50) and Hill coefficient were 1.03+/-0.14 microM and 1.40+/-0.21 respectively. In the case of nafoxidine, these values were 1.61+/-0.29 microM and 1.24+/-0.19. 3. The inhibition induced by the pure enantiomers of clomiphene, zuclomiphene and enclomiphene, was not different from that of the racemic mixture, indicating that the interaction between clomiphene and VRAC is not stereoselective. 4. Clomiphene and nafoxidine inhibited proliferation of CPAE cells. Half-maximal inhibition was found at 1.98+/-0.17 and 1.66+/-0.21 microM respectively, concentrations similar to those for half-maximal block of VRAC. 5. In conclusion, the nonsteroidal partial anti-oestrogens nafoxidine and clomiphene are potent inhibitors of volume-regulated anion channels. The inhibition by clomiphene is not stereoselective and occurs at concentrations close to therapeutically relevant concentrations. Finally, both drugs inhibit the proliferation of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156570      PMCID: PMC1572544          DOI: 10.1038/sj.bjp.0703786

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Regulation of solute and water balance and cell volume in the central nervous system.

Authors:  K Strange
Journal:  J Am Soc Nephrol       Date:  1992-07       Impact factor: 10.121

2.  Inhibition of angiogenesis by antiestrogens.

Authors:  A Gagliardi; D C Collins
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

3.  Lens opacification by antioestrogens: tamoxifen vs ICI 182,780.

Authors:  J J Zhang; T J Jacob; S P Hardy; C F Higgins; M A Valverde
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  [Endocrine fertility-restricting factors in clomiphene therapy].

Authors:  F Jänicke; D Estofan; H Boos; I Böttger
Journal:  Geburtshilfe Frauenheilkd       Date:  1986-04       Impact factor: 2.915

5.  Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous.

Authors:  R Bishai; L Arbour; C Lyons; G Koren
Journal:  Teratology       Date:  1999-09

6.  Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells.

Authors:  M S De Lorenzo; D F Alonso; D E Gomez
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

7.  Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

Authors:  J J Zhang; T J Jacob; M A Valverde; S P Hardy; G M Mintenig; F V Sepúlveda; D R Gill; S C Hyde; A E Trezise; C F Higgins
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

8.  Volume-activated Cl- currents in different mammalian non-excitable cell types.

Authors:  B Nilius; J Sehrer; F Viana; C De Greef; L Raeymaekers; J Eggermont; G Droogmans
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

9.  Permeation properties and modulation of volume-activated Cl(-)-currents in human endothelial cells.

Authors:  B Nilius; J Sehrer; G Droogmans
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

10.  Activation of a Cl- current by hypotonic volume increase in human endothelial cells.

Authors:  B Nilius; M Oike; I Zahradnik; G Droogmans
Journal:  J Gen Physiol       Date:  1994-05       Impact factor: 4.086

View more
  8 in total

1.  DCPIB, a specific inhibitor of volume-regulated anion channels (VRACs), inhibits astrocyte proliferation and cell cycle progression via G1/S arrest.

Authors:  Dan He; Xiang Luo; Wenjie Wei; Minjie Xie; Wei Wang; Zhiyuan Yu
Journal:  J Mol Neurosci       Date:  2011-05-11       Impact factor: 3.444

Review 2.  Diversity of Cl(-) channels.

Authors:  M Suzuki; T Morita; T Iwamoto
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

Review 3.  Biophysics and Physiology of the Volume-Regulated Anion Channel (VRAC)/Volume-Sensitive Outwardly Rectifying Anion Channel (VSOR).

Authors:  Stine F Pedersen; Yasunobu Okada; Bernd Nilius
Journal:  Pflugers Arch       Date:  2016-01-06       Impact factor: 3.657

4.  Inhibition of the endogenous volume-regulated anion channel (VRAC) in HEK293 cells by acidic di-aryl-ureas.

Authors:  N Hélix; D Strøbaek; B H Dahl; P Christophersen
Journal:  J Membr Biol       Date:  2003-11-15       Impact factor: 1.843

5.  Natural and synthetic flavonoids, novel blockers of the volume-regulated anion channels, inhibit endothelial cell proliferation.

Authors:  Yucong Xue; Honglin Li; Yuanyuan Zhang; Xue Han; Gaohua Zhang; Wenya Li; Huiran Zhang; Yue Lin; Pingping Chen; Xiaorun Sun; Yalei Liu; Li Chu; Jianping Zhang; Mingyun Zhang; Xuan Zhang
Journal:  Pflugers Arch       Date:  2018-06-30       Impact factor: 3.657

Review 6.  A 30-year journey from volume-regulated anion currents to molecular structure of the LRRC8 channel.

Authors:  Kevin Strange; Toshiki Yamada; Jerod S Denton
Journal:  J Gen Physiol       Date:  2019-01-16       Impact factor: 4.086

7.  VI-116, A Novel Potent Inhibitor of VRAC with Minimal Effect on ANO1.

Authors:  Dongkyu Jeon; Kunhi Ryu; Sungwoo Jo; Ikyon Kim; Wan Namkung
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 5.923

Review 8.  Ion Channels in Glioma Malignancy.

Authors:  Luigi Catacuzzeno; Luigi Sforna; Vincenzo Esposito; Cristina Limatola; Fabio Franciolini
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.